United States Antimony Co. (NYSE:UAMY) Stock Rated "Moderate Buy" by Wall Street Brokerages

Key Points

• Analysts rate UAMY “Moderate Buy”: Three of five covering analysts rate it Buy, one Strong Buy and one Sell; the average 12-month price target is $8.75. HC Wainwright cut its target from $9.25 to $6.50 while maintaining a Buy rating.
• Quarterly results showed growth but missed expectations: Third-quarter revenue rose 16% year over year to $10.13 million, but UAMY reported a $0.06-per-share loss, wider than analysts expected, and withdrew guidance.
• Shares opened at $3.12, well below their 52-week high of $12.64. The company also reported recent insider purchases totaling 62,700 shares during the quarter.

Shares of United States Antimony Co. (NYSE:UAMY - Get Free Report) have received a consensus rating of "Moderate Buy" from the five analysts that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, three have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $8.75.

Several equities research analysts have recently weighed in on the company. HC Wainwright reduced their price objective on United States Antimony from $9.25 to $6.50 and set a "buy" rating for the company in a research note on Friday. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of United States Antimony in a research report on Monday, September 14th. Wall Street Zen raised United States Antimony from a "strong sell" rating to a "sell" rating in a report on Saturday. Finally, Texas Capital raised United States Antimony to a "strong-buy" rating in a report on Wednesday, October 7th.

United States Antimony Stock Performance

Shares of NYSE:UAMY opened at $3.12 on Friday. The stock has a market capitalization of $467.27 million, a price-to-earnings ratio of -20.81 and a beta of 0.49. United States Antimony has a 1-year low of $2.53 and a 1-year high of $12.64. The company has a 50 day moving average price of $3.77 and a 200 day moving average price of $6.89.

United States Antimony (NYSE:UAMY - Get Free Report) last posted its quarterly earnings results on Thursday, November 12th. The company reported ($0.06) earnings per share (EPS) for the quarter. The business had revenue of $10.13 million during the quarter. United States Antimony had a negative return on equity of 7.73% and a negative net margin of 55.44%. On average, sell-side analysts expect that United States Antimony will post -0.01 EPS for the current fiscal year.

More United States Antimony News

These are some of the UAMY news items that stood out recently:

• Positive Sentiment: Third-quarter revenue rose 16% year over year, to $10.13 million, providing evidence of top-line growth. Read More.
• Neutral Sentiment: HC Wainwright kept its Buy rating but cut its price target from $9.25 to $6.50. The revised target still indicates substantial potential upside from the cited $3.12 price, but the reduction reflects a more cautious outlook. Read More.
• Negative Sentiment: UAMY reported a third-quarter loss of $0.06 per share, wider than the $0.02 loss analysts expected and the $0.04 loss a year earlier. Revenue also missed estimates, while the company’s withdrawal of guidance added uncertainty. These factors were cited in reports of an overnight share decline. Read More. · Read More.

Insider Buying and Selling

In related news, CEO Gary Evans purchased 20,000 shares of the company's stock in a transaction that occurred on Friday, August 28th. The shares were purchased at an average price of $4.92 per share, with a total value of $98,400.00. Following the purchase, the chief executive officer owned 2,590,028 shares of the company's stock, valued at $12,742,937.76. This trade represents a 0.78% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Joseph Carrabba acquired 21,300 shares of the business's stock in a transaction on Tuesday, September 1st. The shares were bought at an average price of $4.72 per share, for a total transaction of $100,536.00. Following the acquisition, the director owned 198,401 shares in the company, valued at approximately $936,452.72. This trade represents a 12.03% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders have purchased 62,700 shares of company stock valued at $298,592. 5.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On United States Antimony

A number of large investors have recently made changes to their positions in UAMY. KBC Group NV acquired a new position in United States Antimony in the 1st quarter worth approximately $31,000. Farther Finance Advisors LLC raised its stake in United States Antimony by 65.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 8,545 shares of the company's stock valued at $36,000 after purchasing an additional 3,372 shares during the period. Axxcess Wealth Management LLC acquired a new stake in United States Antimony during the 3rd quarter valued at $44,000. Inscription Capital LLC acquired a new stake in United States Antimony during the 3rd quarter valued at $47,000. Finally, Wealthfront Advisers LLC purchased a new stake in shares of United States Antimony in the second quarter valued at $85,000. Institutional investors and hedge funds own 9.49% of the company's stock.

United States Antimony Company Profile

United States Antimony Corporation mines, processes and sells antimony and related products. Its offerings include antimony oxide, antimony metal and sodium antimonate, materials used in a range of industrial applications. The company also produces zeolite through its Bear River Zeolite operations in Idaho. Zeolite products are used in applications such as water treatment, agriculture and odor control. Founded in 1968, United States Antimony has processing operations in Montana and Mexico, as well as zeolite operations in Idaho.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.